Name | Phenethipylone |
---|---|
Synonyms |
Methanone,(6-hydroxy-2-(4-hydroxyphenyl)benzo(B)thien-3-yl)(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)
[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl][4-[2-(1-pyrrolidinyl)ethoxy]phenyl]methanone 6-Hydroxy-2-(4-hydroxyphenyl)benzo(B)thien-3-yl 4-(2-(1-pyrrolidinyl)ethoxy) phenyl ketone |
Description | LY117018, a Raloxifene analog, is a selective estrogen receptor modulator. LY117018 exerts antiproliferative effects on breast cancer cell lines[1][2]. |
---|---|
Related Catalog | |
Target |
Estrogen receptor |
In Vitro | LY117018 (0.01-1000 nM; 24 hours) at lower concentrations (0.01-10 nM) caused an E2-like increase in p53 levels when compared to its effects on cells grown in the stripped medium. At a higher concentration of LY117018 (1 μM), the level of p53 appeared to decline. Treatment with 1 μM LY117018 resulted in a predominantly hypophosphorylated pRb. At lower concentrations, LY117018 did not block E2-induced pRb phosphorylation[1]. LY117018 (1 μM; 96 hours) inhibits MCF-7 cells proliferation with an IC50 of 1 μM[2]. LY117018 suppresses oxidative stress-induced endothelial cell apoptosis through activation of ERK1/2 signaling pathway[3]. Cell Proliferation Assay[2] Cell Line: MCF-7 cells Concentration: 1 μM Incubation Time: 96 hours Result: Inhibited MCF-7 cells proliferation with an IC50 of 1 μM. |
References |
Density | 1.314g/cm3 |
---|---|
Boiling Point | 721.5ºC at 760 mmHg |
Molecular Formula | C27H25NO4S |
Molecular Weight | 459.55700 |
Flash Point | 390.2ºC |
Exact Mass | 459.15000 |
PSA | 98.24000 |
LogP | 5.62300 |
Index of Refraction | 1.679 |
Precursor 10 | |
---|---|
DownStream 0 |